Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Monique M. A. Brood-van Zanten"'
Autor:
Majke H. D. van Bommel, Miranda P. Steenbeek, Joanna IntHout, Rosella P. M. G. Hermens, Nicoline Hoogerbrugge, Marline G. Harmsen, Helena C. van Doorn, Marian J. E. Mourits, Marc van Beurden, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, Monique M. A. Brood-van Zanten, M. Caroline Vos, Jurgen M. Piek, Luc R. C. W. van Lonkhuijzen, Mirjam J. A. Apperloo, Sjors F. P. J. Coppus, Judith B. Prins, José A. E. Custers, Joanne A. de Hullu
Publikováno v:
Supportive Care in Cancer, 30, 4, pp. 3409-3418
Supportive Care in Cancer, 30, 3409-3418
Supportive Care in Cancer, 30(4), 3409-3418. Springer, Cham
Supportive Care in Cancer, 30(4), 3409-3418. Springer-Verlag
Supportive care in cancer, 30(4), 3409-3418. Springer Verlag
van Bommel, M H D, Steenbeek, M P, IntHout, J, Hermens, R P M G, Hoogerbrugge, N, Harmsen, M G, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Prins, J B, Custers, J A E & de Hullu, J A 2022, ' Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer : course over time and associated factors ', Supportive Care in Cancer, vol. 30, no. 4, pp. 3409-3418 . https://doi.org/10.1007/s00520-021-06726-4
Supportive Care in Cancer, 30(4), 3409-3418. Springer Verlag
Supportive Care in Cancer, 30, 3409-3418. SPRINGER
Supportive Care in Cancer, 30(4), 3409-3418. SPRINGER
Supportive Care in Cancer, 30, 3409-3418
Supportive Care in Cancer, 30(4), 3409-3418. Springer, Cham
Supportive Care in Cancer, 30(4), 3409-3418. Springer-Verlag
Supportive care in cancer, 30(4), 3409-3418. Springer Verlag
van Bommel, M H D, Steenbeek, M P, IntHout, J, Hermens, R P M G, Hoogerbrugge, N, Harmsen, M G, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Prins, J B, Custers, J A E & de Hullu, J A 2022, ' Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer : course over time and associated factors ', Supportive Care in Cancer, vol. 30, no. 4, pp. 3409-3418 . https://doi.org/10.1007/s00520-021-06726-4
Supportive Care in Cancer, 30(4), 3409-3418. Springer Verlag
Supportive Care in Cancer, 30, 3409-3418. SPRINGER
Supportive Care in Cancer, 30(4), 3409-3418. SPRINGER
Objective High cancer risks, as applicable to BRCA1 and BRCA2 pathogenic variant (PV) carriers, can induce significant cancer concerns. We examined the degree of cancer worry and the course of this worry among BRCA1/2-PV carriers undergoing surgery t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8e54906427e430770ef9b47ec5df55
https://hdl.handle.net/1887/3567912
https://hdl.handle.net/1887/3567912
Autor:
Monique M A Brood-van Zanten, M. Caroline Vos, Nicoline Hoogerbrugge, Majke H.D. van Bommel, Brigitte F. M. Slangen, Miranda P. Steenbeek, Rosella P.M.G. Hermens, Helena C. van Doorn, Marline G. Harmsen, Mirjam J.A. Apperloo, Leon F.A.G. Massuger, Marieke Arts de Jong, Steven Teerenstra, Marian J.E. Mourits, Ronald P. Zweemer, Johan Bulten, Jurgen M.J. Piek, Sjors F.P.J. Coppus, Marc van Beurden, Katja N. Gaarenstroom, Judith B. Prins, Joanna IntHout, Luc R.C.W. van Lonkhuijzen, Joanne A. de Hullu, Angela H.E.M. Maas
Publikováno v:
Steenbeek, M P, Harmsen, M G, Hoogerbrugge, N, de Jong, M A, Maas, A H E M, Prins, J B, Bulten, J, Teerenstra, S, van Bommel, M H D, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M J, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Massuger, L F A G, IntHout, J, Hermens, R P M G & de Hullu, J A 2021, ' Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers : A Nonrandomized Controlled Trial ', JAMA Oncology, vol. 7, no. 8, pp. 1203-1212 . https://doi.org/10.1001/jamaoncol.2021.1590
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association
Item does not contain fulltext IMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd3ab6a57c66f8094cd4c46b7ea1c46
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3